Overview

Zushima Plaster for Treating Knee Osteoarthritis

Status:
Completed
Trial end date:
2017-12-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to further evaluate the clinical efficacy and safety of Zushima plaster for patients in knee osteoarthrosis post-marketing.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Collaborators:
Beijing Hospital
Beijing Hospital of Traditional Chinese Medicine
Beijing Jishuitan Hospital
Beijing Shijitan Hospital
Beijing Shijitan Hospital, Capital Medical University
Gansu Provincial Hospital
General Hospital of Beijing Military Area
Shanghai Municipal Hospital of Traditional Chinese Medicine
Treatments:
Indomethacin
Criteria
Inclusion Criteria:

- Ages 40-75;

- Unilateral or bilateral knee OA, confirmed radiographically;

- Patients taking oral NSAIDs prior to the breakthrough period will be permitted;

- VAS pain score is or above 20mm.

Exclusion Criteria:

- Knee is swollen and hot;

- Allergic to any ingredient in Girald Daphne Bark Plaster (Girald Daphne Bark,
Lithargite, Linseed oil, Red lead) ;

- Congestive Heart Failure and Edema;

- Advanced renal disease;

- Knee joint skin is burst or skin disease or allergies.